The Legend Holdings-backed digital medical platform has raised fresh capital for a series A round led by Qiming Venture Partners.

Liangyihui, a China-based digital medical platform focused on oncology and backed by conglomerate Legend Holdings, has collected more than RMB100m ($15.5m) in a series C round led by Qiming Venture Partners, DealStreetAsia reported yesterday. The round also featured new investors DT Capital Partners, Yuanju Capital Management and Wang Jiaquan’s family office as well as existing…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.